SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-139756
Filing Date
2016-08-15
Accepted
2016-08-15 16:12:51
Documents
69
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11582_110q.htm 10-Q 1299600
2 EX-31.1 a16-11582_1ex31d1.htm EX-31.1 9530
3 EX-31.2 a16-11582_1ex31d2.htm EX-31.2 9537
4 EX-32.1 a16-11582_1ex32d1.htm EX-32.1 6047
5 EX-32.2 a16-11582_1ex32d2.htm EX-32.2 6046
  Complete submission text file 0001104659-16-139756.txt   7710134

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jagx-20160630.xml EX-101.INS 1585913
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jagx-20160630.xsd EX-101.SCH 70788
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jagx-20160630_cal.xml EX-101.CAL 61622
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jagx-20160630_def.xml EX-101.DEF 273771
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT jagx-20160630_lab.xml EX-101.LAB 610533
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jagx-20160630_pre.xml EX-101.PRE 467716
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 161832842
SIC: 2834 Pharmaceutical Preparations